➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Moodys
Express Scripts
Baxter
AstraZeneca

Last Updated: July 9, 2020

DrugPatentWatch Database Preview

Litigation Details for Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp. (D. Del. 2016)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .
Biologic Drugs cited in Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2018-01-12 192 #39;348 patent"), 7,476,652 (the "'652 patent"), 7,713,930 (the "'930 patent…9,526,844, 9,533,105, 9,457,152, 9,592,348, 7,476,652, 7,713,930, and 9,604,008. Within five days the parties…U.S. Patent Nos. 8,603,044 (the "'044 patent"), 8,679,069 (the '"069 patent"…housing" ('844 patent, claim 21; '105 patent, claims 1, 4; '008 patent, claims 1, …#39;044 patent, claims 1, 2, 3, 8-11, 20; '069 patent, claims 1, 2; '486 patent, claims External link to document
2018-05-17 264 Order - -Memorandum and Order 1 The asserted patents are U.S. Pat. Nos. 7,476,652 ("the '652 patent"); 7,713,930 (…069 patent"); 8,992,486 ("the '486 patent"); 9,457,152("the'152 patent"…the OB Pen Patents because the agreement "defines 'equivalent patents' as patents 'claiming…equivalent patents," and would not know which patents qualify as "equivalent patents" without…equivalent patents. Even if "equivalent" is read to modify each of "patents, patent applications External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Moodys
AstraZeneca
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.